Cor Vasa 2021, 63(1):90-91 | DOI: 10.33678/cor.2020.085
Seven-year survival after transapical transcatheter aortic valve implantation for intermediate and high surgical risk or inoperable patients
- Clinic of Cardiac Surgery, Medical Faculty of the Comenius University, National Institute of Cardiovascular Diseases, Bratislava, Slovakia
Keywords: Transapical access, Transcatheter aortic valve implantation
Received: July 22, 2020; Revised: September 22, 2020; Accepted: September 22, 2020; Published: February 25, 2021 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
Hulman M, Beňa M, Gasparovič I, Hudec V, Bezák B, Artemiou P. Seven-year survival after transapical transcatheter aortic valve implantation for intermediate and high surgical risk or inoperable patients. Cor Vasa. 2021;63(1):90-91. doi: 10.33678/cor.2020.085.
References
- Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomized controlled trial. Lancet 2015;385:2477-2484.
Go to original source... 
Go to PubMed... - Testa L, Latib A, Brambilla N, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. Eur Heart J 2020;41:1876-1886. Go to original source... Go to PubMed...
- Eitchaninoff H, Durant E, Avinee G, et al. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition. EuroIntervention 2018;14:e264-e271. Go to original source... Go to PubMed...
- Barbanti M, Costa G, Zappulla P, et al. Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement. J Am Heart Assoc 2018;7:e008440. Go to original source... Go to PubMed...
- Panico RA, Giannini C, De Carlo M, et al. Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years. EuroIntervention 2019;14:1639-1647. Go to original source... Go to PubMed...
- Holy EW, Kebernik J, Abdelghani M, et al. Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardized definitions of structural deterioration and valve failure. EuroIntervention 2018;14:e390-e396. Go to original source... Go to PubMed...
- Deutsch MA, Erlebach M, Burri M, et al. Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices EuroIntervention 2018;14:41-49. Go to original source... Go to PubMed...
- Didier R, Eitchaninoff H, Donzeau-Gouge P, et al. Five-year clinical outcome and durability after transcatheter aortic valve replacement in high-risk patients FRANCE-2 registry. Circulation 2018;138:2597-2607. Go to original source... Go to PubMed...
- Gleason TG, Reardon MJ, Popma JJ, et al. CoreValve U.S Pivotal High Risk Trial Clinical Investigators. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol 2018;72:2687-2696. Go to original source... Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.